We are live on ! Find out more
MRTX

Mirati Therapeutics, Inc. Common Stock

Delisted

MRTX was delisted on the 22nd of January, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
Avoro Capital Advisors
1
Avoro Capital Advisors
New York
$388M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$330M +$13.3M +180,278 +4%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$242M +$41.7M +563,281 +19%
AH
4
Aviva Holdings
Bahamas
$219M – – –
Perceptive Advisors
5
Perceptive Advisors
New York
$194M -$6.07M -82,067 -3%
BlackRock
6
BlackRock
New York
$170M +$1.29M +17,385 +0.7%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$150M +$9.85M +133,158 +7%
BC
8
Boxer Capital
California
$140M – – –
CCM
9
Camber Capital Management
Massachusetts
$140M +$99.9M +1,350,000 +208%
Armistice Capital
10
Armistice Capital
New York
$133M -$11M -148,000 -7%
RTW Investments
11
RTW Investments
New York
$131M – – –
State Street
12
State Street
Massachusetts
$110M -$22.6M -305,076 -16%
Ameriprise
13
Ameriprise
Minnesota
$103M +$581K +7,848 +0.5%
Franklin Resources
14
Franklin Resources
California
$102M +$128K +1,728 +0.1%
OrbiMed
15
OrbiMed
New York
$99.1M +$24.3M +328,492 +30%
Adage Capital Partners
16
Adage Capital Partners
Massachusetts
$99.1M +$105M +1,418,747 New
BBA
17
Baker Bros. Advisors
New York
$98.5M – – –
AG
18
Artal Group
Luxembourg
$92.5M +$16.6M +225,000 +20%
T. Rowe Price Associates
19
T. Rowe Price Associates
Maryland
$79.8M +$6.75M +91,225 +9%
EC
20
EcoR1 Capital
California
$70.9M +$75.1M +1,015,572 New
Morgan Stanley
21
Morgan Stanley
New York
$68.9M +$6.05M +81,721 +9%
RSCM
22
Rock Springs Capital Management
Maryland
$60.5M +$1.61M +21,799 +3%
Paradigm Biocapital Advisors
23
Paradigm Biocapital Advisors
New York
$59.4M +$14.1M +190,417 +29%
Janus Henderson Group
24
Janus Henderson Group
$50.7M -$418K -5,649 -0.8%
Candriam SCA
25
Candriam SCA
Luxembourg
$46.3M +$5.05M +68,217 +11%